Osteoporosis: from cost-effect characteristics to clinical efficacy and safety of strontium ranelate (bivaios)

Osteoporosis: from cost-effect characteristics to clinical efficacy and safety of strontium ranelate (bivaios)

Bibliographic Details
Main Authors:	Ia S Dydykina, V V Tsurko
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2008-05-01
Series:	Терапевтический архив
Subjects:	review osteoporosis cost-effect characteristics of the disease clinical efficacy and safety strontium ranelate (bivalos
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/30198

Similar Items

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01)

Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009-04-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

Strontium ranelate enriched Ruminococcus albus in the gut microbiome of Sprague–Dawley rats with postmenopausal osteoporosis
by: Xiao Xiao, et al.
Published: (2023-11-01)

Influence of Various Strontium Formulations (Ranelate, Citrate, and Chloride) on Bone Mineral Density, Morphology, and Microarchitecture: A Comparative Study in an Ovariectomized Female Mouse Model of Osteoporosis
by: Agnieszka Tomczyk-Warunek, et al.
Published: (2024-04-01)

Efficacy and safety of bivalos therapy for postmenopausal osteoporosis. results of russian multicenter trial
by: L Ia Rozhinskaia, et al.
Published: (2008-05-01)

Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis
by: Kássya Mycaela Paulino Silva, et al.
Published: (2021-04-01)

The Short-Term Effects of Strontium Ranelate on Pain and Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Halil Koyuncu, et al.
Published: (2012-08-01)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012-08-01)

Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis
by: T.A. Rodrigues, et al.

A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate
by: Hanh H Nguyen, et al.
Published: (2017-06-01)

Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
by: Thiago A. Rodrigues, et al.
Published: (2018-09-01)

PATHOGENESIS OF OSTEOARTHRITIS AND SUBSTANTIATION OF THE USE OF STRONTIUM RANELATE
by: Elena Mikhailovna Zaitseva, et al.
Published: (2014-02-01)

Strontium Ranelate and Strontium Chloride Supplementation Influence on Bone Microarchitecture and Bone Turnover Markers—A Preliminary Study
by: Karolina Turżańska, et al.
Published: (2023-12-01)

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
by: T.A. Rodrigues, et al.
Published: (2018-06-01)

Effect of Strontium Ranelate on Condylar Growth during Mandibular Advancement in Rats
by: Hasan Camcı, et al.
Published: (2020-12-01)

Impacto de una alerta sanitaria sobre la utilización de ranelato de estroncio Impact of a health safety warning on strontium ranelate utilization
by: Eduardo Carracedo-Martínez, et al.
Published: (2010-04-01)

Cytotoxicity Analysis of Strontium Ranelate on Cultured Human Periodontal Ligament Fibroblasts: A Preliminary Report
by: Kürşat Er, et al.
Published: (2008-08-01)

STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2017-07-01)

Cumulative Effects of Strontium Ranelate and Impact Exercise on Bone Mass in Ovariectomized Rats
by: Priscilla Aveline, et al.
Published: (2021-03-01)

Effect of strontium ranelate and cerium oxide addition in the diet on egg production and eggshell quality in laying hen
by: PAYAM SADQ SABIR, et al.
Published: (2023-01-01)

Current approaches to the diagnosis and treatment of postmenopausal osteoporosis
by: Irina Aleksandrovna Baranova, et al.
Published: (2009-10-01)

Reversed phase HPLC for strontium ranelate: Method development and validation applying experimental design
by: Kovács Béla, et al.
Published: (2018-06-01)

Evaluation of Biocompatibility of New Osteoplastic Xenomaterials Containing Zoledronic Acid and Strontium Ranelate
by: Maksim V. Stogov, et al.
Published: (2023-06-01)

Strontium ranelate inhibits wear particle-induced aseptic loosening in mice
by: Tianxiang Geng, et al.
Published: (2018-07-01)

Treatment of primary osteoporosis in men
by: Giusti A, et al.
Published: (2014-12-01)

Strontium ranelate retards disc degradation and improves endplate and bone micro-architecture in ovariectomized rats with lumbar fusion induced – Adjacent segment disc degeneration
by: Qi Sun, et al.
Published: (2024-03-01)

Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/β-catenin pathway
by: Hao Yu, et al.
Published: (2021-05-01)

Effect of strontium ranelate and cerium oxide addition in the diet on bone quality and expression level of osteocalcin and alkaline phosphatase genes in broiler chicken
by: Payam Sadq Sabir, et al.
Published: (2023-07-01)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

STUDY OF ENDOTHELIAL PROTECTIVE AND OSTEOPROTECTIVE PROPERTIES OF ROSUVASTATIN, L-NORVALINE AND THEIR COMBINATIONS IN EXPERIMENTAL OSTEOPOROSIS
by: M. S. SOBOLEV, et al.
Published: (2017-12-01)

Strontium Ranelate Inhibits Osteoclastogenesis through NF-κB-Pathway-Dependent Autophagy
by: Dongle Wu, et al.
Published: (2023-03-01)

Strontium and Osteoporosis
by: Ferda Özdemir, et al.
Published: (2004-06-01)

Osteogenesis capability of three-dimensionally printed poly(lactic acid)-halloysite nanotube scaffolds containing strontium ranelate
by: Boraei Seyyed Behnam Abdollahi, et al.
Published: (2022-05-01)

Osteoinductivity and Antibacterial Properties of Strontium Ranelate-Loaded Poly(Lactic-co-Glycolic Acid) Microspheres With Assembled Silver and Hydroxyapatite Nanoparticles
by: Zhenyang Mao, et al.
Published: (2018-04-01)

THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN
by: Ivan Koklin, et al.
Published: (2015-12-01)

Strontium Functionalization of Biomaterials for Bone Tissue Engineering Purposes: A Biological Point of View
by: Giorgia Borciani, et al.
Published: (2022-02-01)

Clinical and radiographic diagnostic study of strontium ranelate andmetal-substituted hydroxyapatite bone graft materials in diabetesmellitus with chronic periodontitis
by: Omar Khashaba, et al.
Published: (2020-12-01)